Contact
Please use this form to send email to PR contact of this press release:
Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy
TO:
Please use this form to send email to PR contact of this press release:
Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy
TO: